...
首页> 外文期刊>Biotechnology Progress >Poly(ethylene glycol) Methacrylate/Dimethacrylate Hydrogels for Controlled Release of Hydrophobic Drugs
【24h】

Poly(ethylene glycol) Methacrylate/Dimethacrylate Hydrogels for Controlled Release of Hydrophobic Drugs

机译:聚(甲基)丙烯酸甲酯/二甲基丙烯酸甲酯水凝胶用于疏水性药物的控释

获取原文
获取原文并翻译 | 示例
           

摘要

Hydrogels have been successfully used to entrap hydrophilic drugs and release them in a controlled fashion;however,the entrapment and release of hydrophobic drugs has not been well studied.We report on the release characteristics of a model hydrophobic drug,the steroid hormone estradiol,entrapped in low (MW 360/MW 550) and high (MW 526/MW 1000) molecular weight poly(ethylene glycol) methacrylate (PEG-MA)/dimethacrylate (PEG-DMA) hydrogels.The cross-linking ratio,temperature,and pH ranged from 10:1 to 10:3,from 33 to 41 °C,and from 2 to 12,respectively.The gelation of the PEG-MA/PEG-DMA hydrogel was initiated with UV irradiation.The absence of poly(glutamic acid) in the hydrogel formulation resulted in a loss of pH sensitivity in the acidic range,which was displayed by the hydrogels' similarities in swelling ratios in the pH buffers of pH 2,4,and 7.Use of high molecular weight polymers resulted in a higher hydrogel swelling (300%) in comparison to the low molecular weight polymers.Drug size was found to be a significant factor.In comparison to 100% estradiol (MW 272) release,the fractional release of insulin (MW 5733) was 12 and 24% in low and high molecular weight gels at pH 2,respectively,and 17% in low molecular weight gels at pH 7.On the release kinetics of the estradiol drug,the hydrogels displayed a non-Fickian diffusion mechanism,which indicated that the media penetration rate is in the same range as the drug diffusion.The synthesis,entrapment,and release of estradiol by the PEG-MA/PEG-DMA hydrogels proved to be successful,but the use of ethanol in the buffers to promote the hydrophobic release of the estradiol in the in vitro environment caused complications,attributed to the process of transesterification.
机译:水凝胶已被成功地用于捕获亲水性药物并以受控方式释放它们;但是,对疏水性药物的捕获和释放尚未进行充分的研究。我们报道了疏水性模型药物类固醇激素雌二醇的截获和释放在低分子量(MW 360 / MW 550)和高分子量(MW 526 / MW 1000)的聚乙二醇甲基丙烯酸甲酯(PEG-MA)/二甲基丙烯酸酯(PEG-DMA)水凝胶中的交联比,温度和pH分别从10:1到10:3,从33到41°C和从2到12的范围.PEG-MA / PEG-DMA水凝胶的凝胶化是通过紫外线照射开始的。 )在水凝胶配方中导致pH灵敏度在酸性范围内下降,这表现为水凝胶在pH 2,4和7的pH缓冲液中溶胀率的相似性。使用高分子量聚合物会导致与低分子量聚合物相比,水凝胶溶胀更高(300%)。与100%雌二醇(MW 272)释放相比,在pH 2的低分子量和高分子量凝胶中,胰岛素(MW 5733)的分别释放率为12%和24%,分别为17和17 pH为7的低分子量凝胶中的%含量。在雌二醇药物的释放动力学上,水凝胶显示出非菲克式扩散机理,这表明介质的渗透速率与药物扩散处于同一范围内。 ,并证明PEG-MA / PEG-DMA水凝胶释放雌二醇是成功的,但在体外环境中在缓冲液中使用乙醇促进雌二醇的疏水性释放引起并发症,这归因于酯交换反应的过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号